The P2P CPP team aims to develop a safe and efficient means of getting drugs into cells. The P2P CPP project has broad application potentials for drugs with intracellular targets. STipe Therapeutics is industry partner in the P2P CPP project.
On this page, you can find all of the news from ODIN, which is related to the P2P CPP project. If you are curious about more information, you are always welcome to contact Hanne Poulsen, who is head of the P2P CPP project.
P2P CPP is short for "Optimization of cell-penetrating peptides to enable therapeutics with intracellular targets".
In ODIN, all findings and results will be shared openly.
Researchers working on ODIN projects are encouraged to upload all of their findings to the ODIN community on Zenodo - see the link to the right.
If you have any questions, you are more than welcome to contact the ODIN secretariat.